149 related articles for article (PubMed ID: 11774081)
1. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.
Harris AD; Smith D; Johnson JA; Bradham DD; Roghmann MC
Clin Infect Dis; 2002 Feb; 34(3):340-5. PubMed ID: 11774081
[TBL] [Abstract][Full Text] [Related]
2. [A case-control study on the risk factors of nosocomial infection caused by imipenem-resistant Pseudomonas aeruginosa].
Peng SH; Jin ZJ; Luo L; Li CR
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul; 26(7):511-4. PubMed ID: 16335003
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
Zavascki AP; Cruz RP; Goldani LZ
J Hosp Infect; 2005 Feb; 59(2):96-101. PubMed ID: 15620442
[TBL] [Abstract][Full Text] [Related]
4. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
Ozkurt Z; Ertek M; Erol S; Altoparlak U; Akcay MN
Burns; 2005 Nov; 31(7):870-3. PubMed ID: 15975720
[TBL] [Abstract][Full Text] [Related]
5. Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality.
Furtado GH; Bergamasco MD; Menezes FG; Marques D; Silva A; Perdiz LB; Wey SB; Medeiros EA
J Crit Care; 2009 Dec; 24(4):625.e9-14. PubMed ID: 19592213
[TBL] [Abstract][Full Text] [Related]
6. Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
Onguru P; Erbay A; Bodur H; Baran G; Akinci E; Balaban N; Cevik MA
J Korean Med Sci; 2008 Dec; 23(6):982-7. PubMed ID: 19119440
[TBL] [Abstract][Full Text] [Related]
7. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli.
Harris AD; Samore MH; Lipsitch M; Kaye KS; Perencevich E; Carmeli Y
Clin Infect Dis; 2002 Jun; 34(12):1558-63. PubMed ID: 12032889
[TBL] [Abstract][Full Text] [Related]
8. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
J Infect; 2006 Jul; 53(1):30-5. PubMed ID: 16253333
[TBL] [Abstract][Full Text] [Related]
10. Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms.
Lepelletier D; Cady A; Caroff N; Marraillac J; Reynaud A; Lucet JC; Corvec S
Diagn Microbiol Infect Dis; 2010 Jan; 66(1):1-6. PubMed ID: 19775845
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
Cao B; Wang H; Sun H; Zhu Y; Chen M
J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
[TBL] [Abstract][Full Text] [Related]
12. Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
Krcmery V; Trup J; Kunova A; Spanik S; Drgona L; Oravcova E; Studena M; Lacka J; Sevcikova L; Koren P; Kukuckova E; Stopkova K; Krupova I; Grausova S; Svec J
Int J Clin Pharmacol Res; 1996; 16(2-3):43-9. PubMed ID: 9063755
[TBL] [Abstract][Full Text] [Related]
13. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes.
Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
Infect Control Hosp Epidemiol; 2010 Jan; 31(1):47-53. PubMed ID: 19951202
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for recovery of imipenem- or ceftazidime-resistant pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil.
Fortaleza CM; Freire MP; Filho Dde C; de Carvalho Ramos M
Infect Control Hosp Epidemiol; 2006 Sep; 27(9):901-6. PubMed ID: 16941313
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.
Mammina C; Di Carlo P; Cipolla D; Casuccio A; Tantillo M; Plano MR; Mazzola A; Corsello G
Acta Pharmacol Sin; 2008 Dec; 29(12):1486-92. PubMed ID: 19026168
[TBL] [Abstract][Full Text] [Related]
16. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
Turner PJ
Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
[TBL] [Abstract][Full Text] [Related]
17. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.
Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G
Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152
[TBL] [Abstract][Full Text] [Related]
18. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
Cezário RC; Duarte De Morais L; Ferreira JC; Costa-Pinto RM; da Costa Darini AL; Gontijo-Filho PP
Enferm Infecc Microbiol Clin; 2009 May; 27(5):269-74. PubMed ID: 19386392
[TBL] [Abstract][Full Text] [Related]
19. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
20. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
